(MENAFN- News Direct) London, UK | February 08, 2023 08:47 AM Eastern Standard Time
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner about how the business performed during the fourth quarter of 2022. Clements says that the 'numbers were very good' and reveals more details about how the business is changing as it heads into a new calendar year.
Proactive UK Finance News
MENAFN08022023005728012573ID1105544937
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.